Acute myocardial infarction following erlotinib treatment for NSCLC: A case report

  • Authors:
    • Shanshan Ding
    • Fei Long
    • Shujuan Jiang
  • View Affiliations

  • Published online on: April 28, 2016     https://doi.org/10.3892/ol.2016.4508
  • Pages: 4240-4244
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, is an oral targeted anticancer drug that is used to treat non‑small cell lung cancer (NSCLC). Previous studies have confirmed that erlotinib is safe and is well-tolerated by patients. The most common adverse reactions observed following erlotinib treatment include a rash and mild diarrhea. In the current study, the first case of acute myocardial infarction following one month of treatment with erlotinib in a 63‑year‑old male NSCLC patient is presented. The present study highlights the importance of clinicians remaining cautious following erlotinib administration. In elderly NSCLC patients and those with a history of coronary heart disease, cardiac function must be carefully monitored following erlotinib treatment so that serious adverse reactions, such as myocardial infarction, may be identified early and treated quickly.
View Figures
View References

Related Articles

Journal Cover

June-2016
Volume 11 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ding S, Long F and Jiang S: Acute myocardial infarction following erlotinib treatment for NSCLC: A case report. Oncol Lett 11: 4240-4244, 2016
APA
Ding, S., Long, F., & Jiang, S. (2016). Acute myocardial infarction following erlotinib treatment for NSCLC: A case report. Oncology Letters, 11, 4240-4244. https://doi.org/10.3892/ol.2016.4508
MLA
Ding, S., Long, F., Jiang, S."Acute myocardial infarction following erlotinib treatment for NSCLC: A case report". Oncology Letters 11.6 (2016): 4240-4244.
Chicago
Ding, S., Long, F., Jiang, S."Acute myocardial infarction following erlotinib treatment for NSCLC: A case report". Oncology Letters 11, no. 6 (2016): 4240-4244. https://doi.org/10.3892/ol.2016.4508